-
-
- R&D Unit
- Industrial Vaccine Production Unit
- Vaccine and Immunization Training Unit
- Vaccine Epidemiology Unit
- Preclinical and Clinical Research and Project Coordination Unit
- Epidemiology of Pandemic-Risk Infectious Agents Unit
- Bioterrorism Unit
- Laboratory Animal Production/Testing and Preclinical Research Unit
- Tissue Culture Collection, Viral and Bacterial Culture Banking Unit
- Quality Control Laboratory Unit
- Training, Administrative, and Financial Services Unit
-
-
-
- Announcements
- Key Dates
- FAQ
- Contact
Last Added News
- Will There Be a New Pandemic?
- The article titled Portraits from Our Medical History: Dr. Tevfik Salim Sağlam has been published.
- The article titled Questions on Immunization and Vaccination and Short Answers has been published.
- Diphtheria Epidemiology in Türkiye Throughout History Has Been Published
- Portraits from Our Medical History: Dr. Elhan Özlüarda (1927-2013) Has Been Published
- ALL NEWS
Workshop on Insurance in Clinical Research
The "Workshop on Insurance in Clinical Research," organized through the collaboration of the Health Institutes of Türkiye (TÜSEB) – Türkiye Vaccine Institute (TAE) and the Turkish Medicines and Medical Devices Agency (TİTCK), was held on September 14, 2023, at TÜSEB Aziz Sancar Research Center in Ankara. The program commenced with the opening addresses of Prof. Ateş KARA, MD, Head of Türkiye Vaccine Institute, Elif İnci ERGÖNÜL, PhD, Head of the Clinical Trials Department of TİTCK, and Fatih TOPUZ, Head of the Medical Device Notified Body and Clinical Trials Department of TİTCK.
The workshop, held at the TÜSEB Aziz Sancar Research Center, featured insights and perspectives from various stakeholders, including the Ministry of Health General Directorate of Legal Services, Health Institutes of Türkiye (TÜSEB), Turkish Medicines and Medical Devices Agency (TİTCK), and the Insurance and Private Pension Regulation and Supervision Agency (SEDDK). Representatives from key industry associations, such as the Association of Research-Based Pharmaceutical Companies (AİFD), the Clinical Research Association (KAD), the Association of Contract Research Organizations (SAKDER), and the Insurance Association of Türkiye (TSB), also actively participated in the discussions.
The scope of the workshop encompassed the current challenges and potential solutions encountered by insurance companies and relevant stakeholders within the Turkish clinical research landscape. Key topics included addressing existing insurance-related issues, planning short, medium, and long-term improvement initiatives, and enhancing the global efficacy of insurance frameworks in clinical trials. Following the evaluation of these challenges, solutions, and recommendations, an interim report will be prepared and submitted to the representatives of the relevant public institutions and our Presidency. The next session is scheduled to take place in December 2023.
We would like to extend our sincere gratitude to all participants for their invaluable contributions.
